Aspirin induces apoptosis in vitro and inhibits tumor growth of human hepatocellular carcinoma cells in a nude mouse xenograft model

International Journal of Oncology

Volumn 40, Issue 4, 2012, Pages 1298-1304

  Hossain, Mohammad Akbar ^a   Kim, Dong Hwan ^a   Jang, Jung Yoon ^a   Kang, Yong Jung ^a   Yoon, Jeong Hyun ^a   Moon, Jeon Ok ^a   Chung, Hae Young ^a   Kim, Gi Young ^b   Choi, Yung Hyun ^c   Copple, Bryan L ^d   Kim, Nam Deuk ^a  

^a Pusan National University   (South Korea)

^b Jeju National University   (South Korea)

^c Dong Eui University   (South Korea)

^d MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; Aspirin; Hepatocellular carcinoma; Xenograft model

Indexed keywords

ACETYLSALICYLIC ACID; ANTINEOPLASTIC AGENT; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; ASPIRIN; CARCINOMA, HEPATOCELLULAR; CELL GROWTH PROCESSES; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84863337989     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1304     Document Type: Article

References (37)

1. GLOBOCAN 2008: Cancer fact sheet. http://globocan.iarc.fr/factsheets/ cancers.
2. Simonetti RG, Liberati A, Angiolini C and Pagliaro L: Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trails. Ann Oncol 8: 117-136, 1997. (Pubitemid 27112878)
3. Weiman A, Oldhafer KJ and Pichlmayr R: Primary liver cancer. Curr Opin Oncol 7: 387-396, 1995.
4. Gasic GJ, Gasic TB and Stewart CC: Anti-metastatic effects associated with platelet reduction. Proc Natl Acad Sci USA 61: 46-52, 1968.
5. Gasic GJ, Gasic TB and Murphy S: Anti-metastatic effect of aspirin. Lancet 2: 932-933, 1972.
6. Kolenich JJ, Mansour EG and Flynn A: Haematological effects of aspirin. Lancet 2: 714, 1972.
7. Jaffe BM: Prostaglandin and cancer: an update. Prostaglandins 6: 453-461, 1974.
8. Bennett A and Del TM: Proceedings: prostaglandins in human colonic carcinoma. Gut 16: 409, 1975.
9. Herschman HR: Prostaglandin synthase 2. Biochim Biophys Acta 1299: 125-140, 1996.
10. Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231: 232-235, 1971.
11. Chell S, Kadi A, Williams AC and Paraskeva C: Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of cancer. Biochim Biophys Acta 1766: 104-119, 2006. (Pubitemid 44202570)
12. Wang D and DuBois RN: Prostaglandins and cancer. Gut 55: 115-122, 2006. (Pubitemid 41820645)
13. Kashfi K and Rigas B: Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention. Biochem Pharmacol 70: 969-986, 2005. (Pubitemid 41262072)
14. Shureiqi I, Xu X and Chen D: Nonsteroidal anti-inflammatory drugs induce apoptosis in esophageal cancer cells by restoring 15-lipoxygenase-1 expression. Cancer Res 61: 4879-4884, 2001. (Pubitemid 32691905)
15. Zhang Z and DuBois RN: Par-4, a proapoptotic gene, is regulated by NSAIDs in human colon carcinoma cells. Gastroenterol 118: 1012-1017, 2000. (Pubitemid 30346976)
16. Zhang L, Yu J, Park BH, Kinzler KW and Vogelstein B: Role of BAX in the apoptotic response to anticancer agents. Science 290: 989-992, 2000.
17. Bellosillo B, Pique M and Barragan M: Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukaemia cells. Blood 92: 1406-1414, 1998. (Pubitemid 28369055)
18. Raza H, John A and Benedict S: Acetylsalicylic acid-induced oxidative stress, cell cycle arrest, apoptosis and mitochondrial dysfunction in human hepatoma HepG2 cells. Eur J Pharmacol 668: 15-24, 2011.
19. Schwenger P, Bellosta P, Vietor I, Basilico C, Skolnik Y and Vilcek J: Sodium salicylate induces apoptosis via p38 mitogen activated protein kinase but inhibits tumour necrosis factor-induced c-Jun N-terminal kinase/ stress-activated protein kinase activation. Proc Natl Acad Sci USA 94: 2869-2873, 1997. (Pubitemid 27157231)
20. Zimmermann KC, Waterhouse NJ, Goldstein JC, Schuler M and Green DR: Aspirin induces apoptosis through release of cytochrome c from mitochondria. Neoplasia 2: 505-513, 2000. (Pubitemid 32098685)
21. Chan TA, Morin PJ, Vogelstein B and Kinzler KW: Mechanisms underlying non-steroidal anti-inflammatory drug-mediated apoptosis. Proc Natl Acad Sci USA 95: 681-686, 1998. (Pubitemid 28083803)
22. Zhou XM, Wong BC and Fan XM: Non-steroidal anti-inflammatory drugs induce apoptosis in gastric cancer cells through up-regulation of bax and bak. Carcinogenesis 22: 1393-1397, 2001. (Pubitemid 32898695)
23. Mahdi JG, Alkarrawi MA, Mahdi AJ, Bowen ID and Humam D: Calcium salicylate-mediated apoptosis in human HT01080 fibrosarcoma cells. Cell Prolif 39: 249-260, 2006. (Pubitemid 44035900)
24. Chinnaiyan AM and Dixit VM: The cell-death machine. Curr Biol 6: 555-562, 1996. (Pubitemid 126656312)
25. Kasibhatla S and Tseng B: Why target apoptosis in cancer treatment? Mol Cancer Ther 2: 573-580, 2003.
26. Makin G: Targeting apoptosis in cancer chemotherapy. Expert Opin Ther Targets 6: 73-84, 2002.
27. Johnstone RW, Ruefli AA and Lowe SW: Apoptosis: a link between cancer genetics and chemotherapy. Cell 108: 153-164, 2002. (Pubitemid 34161136)
28. Xiang S, Sun Z, He Q, Yan F, Wang Y and Zhang J: Aspirin inhibits ErbB2 to induce apoptosis in cervical cancer cells. Med Oncol 27: 379-387, 2010.
29. Lee JH, Park SE, Hossain MA, Kim MY, Kim MN, Chung HY, Choi JS, Yoo YH and Kim ND: 2,3,6-Tribromo-4,5-dihydroxybenzyl methyl ether induces growth inhibition and apoptosis in MCF-7 human breast cancer cells. Arch Pharm Res 30: 1132-1137, 2007.
30. Park SE, Park C, Skim SH, Hossain MA, Kim MY, Chung HY, Son WS, Kim GY, Choi YH and Kim ND: Korean red ginseng extract induces apoptosis and decreases telomerase activity in human leukemia cells. J Ethnopharmacol 121: 304-312, 2009.
31. Park SE, Lee SW, Hossain MA, Kim MY, Kim MN, Ahn EY, Park YC, Suh HS, Kim GY, Choi YH and Kim ND: A chenodeoxycholic derivative, HS-1200, induces apoptosis and cell cycle modulation via Egr-1 gene expression control on human hepatoma cells. Cancer Lett 270: 77-86, 2008.
32. Oltvai ZN, Milliman CL and Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619, 1993. (Pubitemid 23259742)
33. Rosse T, Olivier R, Monney L, Rager M, Conus S and Fellay I: Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature 391: 496-499, 1998. (Pubitemid 28086551)
34. Zou H, Li X and Wang X: An Apaf-1, cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem 274: 11549-11556, 1999.
35. Burz C, Berindan-neagoe I, Balacescu O and Irimie A: Apoptosis in cancer: key molecular signaling pathways and therapy targets. Acta Oncol 48: 811-821, 2009.
36. Wolf BB and Green DR: Suicidal tendencies: apoptotic cell death by caspase family proteinases. J Biol Chem 274: 20049-20052, 1999.
37. Stark LA, Reid K, Sansom OJ, Din FV, Guichard S, Mayer I, Jodrell DI, Clarke AR and Dunlop MG: Aspirin activates the NF-κB signaling pathway and induces apoptosis in intestinal neoplasia in two in vivo models of human colorectal cancer. Carcinogenesis 28: 968-976, 2007. (Pubitemid 47072180)